Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
TSX:PRN
Total Valuation
Profound Medical has a market cap or net worth of C$273.65M. The enterprise value is C$90.85M.
Market CapC$273.65M
Enterprise ValueC$90.85M
Share Statistics
Profound Medical has 36,293,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,293,640
Owned by Insiders2.60%
Owned by Institutions32.84%
Financial Efficiency
Profound Medical’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -31.11%.
Return on Equity (ROE)-0.65
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-31.11%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee158.41K
Profits Per Employee-418.89K
Employee Count142
Asset Turnover0.12
Inventory Turnover0.58
Valuation Ratios
The current PE Ratio of Profound Medical is ―. Profound Medical’s PEG ratio is -0.07.
PE Ratio―
PS Ratio14.48
PB Ratio3.58
Price to Fair Value3.58
Price to FCF-6.07
Price to Operating Cash Flow-4.15
PEG Ratio-0.07
Income Statement
In the last 12 months, Profound Medical had revenue of 22.49M and earned -59.48M in profits. Earnings per share was -1.97.
Revenue22.49M
Gross Profit15.92M
Operating Income-57.64M
Pretax Income-59.13M
Net Income-59.48M
EBITDA-56.86M
Earnings Per Share (EPS)-1.97
Cash Flow
In the last 12 months, operating cash flow was -40.65M and capital expenditures -245.93K, giving a free cash flow of -40.90M billion.
Operating Cash Flow-40.65M
Free Cash Flow-40.90M
Free Cash Flow per Share-1.13
Dividends & Yields
Profound Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.61
52-Week Price Change-24.83%
50-Day Moving Average9.69
200-Day Moving Average8.47
Relative Strength Index (RSI)36.44
Average Volume (3m)24.45K
Important Dates
Profound Medical upcoming earnings date is May 13, 2026, After Close (Confirmed).
Last Earnings DateMar 5, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Profound Medical as a current ratio of 12.52, with Debt / Equity ratio of 7.09%
Current Ratio12.52
Quick Ratio11.17
Debt to Market Cap0.02
Net Debt to EBITDA1.33
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Profound Medical has paid 352.12K in taxes.
Income Tax352.12K
Effective Tax Rate>-0.01
Enterprise Valuation
Profound Medical EV to EBITDA ratio is -4.40, with an EV/FCF ratio of -4.67.
EV to Sales11.12
EV to EBITDA-4.40
EV to Free Cash Flow-4.67
EV to Operating Cash Flow-4.69
Balance Sheet
Profound Medical has C$81.87M in cash and marketable securities with C$6.46M in debt, giving a net cash position of C$75.41M billion.
Cash & Marketable SecuritiesC$81.87M
Total DebtC$6.46M
Net CashC$75.41M
Net Cash Per ShareC$2.08
Tangible Book Value Per ShareC$3.01
Margins
Gross margin is 70.25%, with operating margin of -256.27%, and net profit margin of -264.44%.
Gross Margin70.25%
Operating Margin-256.27%
Pretax Margin-262.88%
Net Profit Margin-264.44%
EBITDA Margin-252.79%
EBIT Margin-256.27%
Analyst Forecast
The average price target for Profound Medical is C$16.42, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$16.42
Price Target Upside115.20% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast72.03%
EPS Growth Forecast-1.47%